Safety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia

Stopped early · Phase 3

Conditions studied: Schizophrenia

In brief

The purpose of this study is to assess the safety and tolerability of ziprasidone during long-term open-label administration in adolescents (ages 13-17) with schizophrenia.

Key facts

Study ID

NCT00265382

Run by

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

People needed

221

Starts

2006-06-01

Expected to finish

2009-06-01

Last updated by the study team

2021-03-03

Who can join

Age: 13 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participation in double-blind treatment study A1281134, meeting specific criteria of duration and safety

You may not qualify if…

• Imminent risk of suicide or homicide, as judged by the site investigator
• Serious adverse event related to study medication in study A1281134
• Significant prolongation of QT interval in study A1281134

Where it is running

• Pfizer Investigational Site — Birmingham, Alabama, United States
• Pfizer Investigational Site — Birmingham, Alabama, United States
• Pfizer Investigational Site — San Diego, California, United States
• Pfizer Investigational Site — Denver, Colorado, United States
• Pfizer Investigational Site — Washington D.C., District of Columbia, United States
• Pfizer Investigational Site — Altamonte Springs, Florida, United States
• Pfizer Investigational Site — Orange City, Florida, United States
• Pfizer Investigational Site — Smyrna, Georgia, United States
• Pfizer Investigational Site — Tucker, Georgia, United States
• Pfizer Investigational Site — Des Plaines, Illinois, United States
• Pfizer Investigational Site — Oakbrook Terrace, Illinois, United States
• Pfizer Investigational Site — Schaumburg, Illinois, United States
• Pfizer Investigational Site — Clinton Township, Michigan, United States
• Pfizer Investigational Site — Bridgeton, Missouri, United States
• Pfizer Investigational Site — St Louis, Missouri, United States
• Pfizer Investigational Site — Buffalo, New York, United States
• Pfizer Investigational Site — Rochester, New York, United States
• Pfizer Investigational Site — Cincinnati, Ohio, United States
• Pfizer Investigational Site — Cincinnati, Ohio, United States
• Pfizer Investigational Site — Cincinnati, Ohio, United States
• Pfizer Investigational Site — Cleveland, Ohio, United States
• Pfizer Investigational Site — Oklahoma City, Oklahoma, United States
• Pfizer Investigational Site — Oklahoma City, Oklahoma, United States
• Pfizer Investigational Site — Bothell, Washington, United States
• Pfizer Investigational Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.